About Course #L0890
Review Date: July 13, 2018
Expiration Date: July 13, 2021
Original Release Date: June 26, 2015
Both periodontal disease and osteoporosis are serious public-health concerns in the United States. This intermediate-level course addresses concepts regarding links between oral health and osteoporosis, discusses the impact on oral health of pharmacotherapies used in the treatment of osteoporosis, and outlines steps to mitigate the impact on oral health of common drug treatments used to treat osteoporosis. Oral healthcare providers must recognize the oral health implications of common therapeutic options for osteoporosis, especially use of bisphosphonates and antiresorptive medications.
AGD Subject Code: 730
- Describe the etiology and prevalence of osteoporosis.
- Discuss the putative association between osteoporosis and periodontal disease.
- Explain the pharmacological treatment of osteoporosis.
- Describe the oral health implications of medically related jaw necrosis.
- Identify evidence-based guidelines for the management of bisphosphonate-treated patients.
- Describe the importance of screening for osteoporosis.
Western Schools designates this activity for 3 continuing education credits.
About the Author(s)
John F. Kross, DMD, MSc, received his doctor of dental medicine degree from Temple University School of Dentistry in Philadelphia, Pennsylvania. He completed a fellowship at Temple University Hospital in oral oncology and received a hospital appointment to the Department of Dentistry at the Medical Centers of Delaware (now the Christiana Health Care System). His professional training and experience includes practicing general dentistry in Wilmington, Delaware, and New London, Pennsylvania, as well as instructing students in oral pathology at Delaware Technical Community College. He has displayed a long-term commitment to contributing to continuing dental education and has received numerous academic awards for his work in oral surgery, fixed partial prosthodontics, periodontics, and endodontics. Dr. Kross has received numerous academic awards for his work in oral surgery, fixed partial prosthodontics, periodontics, and endodontics. He is cofounder of Dental Regulatory Associates, a company specializing in U.S. Food and Drug Administration approval of dental drugs and devices.
- Courses must be completed on or before the expiration date noted in the course description above.
- You must score 75% or higher on the final exam and complete the course evaluation to pass this course and receive a certificate of completion.
- Through our review processes, Western Schools ensures that the course content is presented in a balanced, unbiased manner and is free from commercial influence. It is Western Schools' policy not to accept commercial support.
- All persons involved in the planning and development of this course have disclosed no relevant financial relationships or other conflicts of interest related to the course content.
- There are no prerequisites for this course.